International Isotopes Inc. Depleted Uranium Project Nuclear Regulatory Commission Licensing Remains on Course
IDAHO FALLS, Idaho, Jan. 17, 2012 /PRNewswire/ — International Isotopes Inc. (OTC Bulletin Board: INIS), announces the NRC has commenced the public notification and comment period on the draft EIS for the Company’s planned depleted uranium de-conversion facility. As a part of the public comment period process, the NRC plans a public meeting in Hobbs, New Mexico on February 2, 2012. In addition to the public meeting, comments on the project and the draft EIS will be taken until February 27, 2012.
The application and information about the NRC license review process are available on the NRC website at http://www.nrc.gov/materials/fuel-cycle-fac/inisfacility.html. The Draft EIS is available in the NRC’s ADAMS online database by entering Accession Number ML12001A000 in the Content Search box.
The NRC will accept written comments on the Draft EIS through Feb. 27. Comments may be submitted online at http://www.regulations.gov using Docket ID NRC-2010-0143, or mailed to Cindy Bladey, Chief, Rules, Announcements and Directives Branch (RADB), Division of Administrative Services, Office of Administration, Mail Stop: TWB-05-B01M, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555-0001. Include Docket ID NRC-2010-0143 in the subject line. You may also fax your comments to RADB at (301) 492-3446; include Docket ID NRC-2010-0143 in the subject line.
Steve T. Laflin, Company President and CEO, stated, “The publication of the draft EIS and start of this final public comment period is another major milestone in our progress towards licensing this facility. This has been a multi-year process and I credit the hard work of our licensing team and the NRC staff with helping to keep the licensing process on track. The NRC currently anticipates completion of this licensing process and issuing the license for the facility in mid to late summer of 2012. In the next few months, the exact timing of the NRC license issuance will become much clearer and allow the Company to complete financing and start construction on this important project.”
About International Isotopes Inc.
International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients. The Company is in the licensing and design phase of its planned environmentally friendly, green technology, uranium de-conversion and fluorine extraction processing facility located near Hobbs, New Mexico.
International Isotopes Inc. Safe Harbor Statement
Certain statements in this press release or in other documents filed by the Company are “forward-looking statements” within the meaning of applicable United States and Canadian securities laws, including statements with respect to its planned depleted uranium de-conversion and fluorine extraction facility. In particular, statements regarding the Company’s expectations for the schedule for licensing this facility, completing financing for the project, and the timing for the start construction, are forward looking. Information contained in such forward-looking statements is based on current expectations and is subject to change. These statements involve a number of risks, uncertainties, and other factors that could cause actual results, performance or achievements of International Isotopes, Inc. to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in International Isotopes, Inc.’s filings with the Securities and Exchange Commission at www.sec.gov and with certain of the Canadian securities regulatory authorities at www.sedar.com, including our annual report on Form 10-K for the year ending December 31, 2010. Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and International Isotopes, Inc. undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
Investors and shareholders are invited to send their email to email@example.com to be added to the Company’s email database for future news releases.
FOR MORE INFORMATION CONTACT:
For more information, please visit the Company web site: www.intisoid.com
SOURCE International Isotopes Inc.